Arcturus Therapeutics Holdings Inc
ARCT
$14.73+5.36%
End of day · as of Sep 11, 2026, 5:16 PM ET
Mkt cap
$369.38M
EV/Sales
1.69
P/E ratio
N/A
FY2025 Revenue
$82.03M
EPS (TTM)
$-3.33
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-80.19%
Beta
2.29
Div yield
N/A
Sector
Healthcare
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Latest reported ARCT revenue for 2025-12-31 was $82.0M. Net income was -$65.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ARCT currently screens at market cap $369.4M.
Use this ARCT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARCT income, balance, and cash tables.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company in the Healthcare sector.
Latest cached Arcturus Therapeutics Holdings Inc (ARCT) revenue for Dec 31, 2025 was $82.0M. Net income was -$65.8M. Statements: https://lician.com/financials/arct
Arcturus Therapeutics Holdings Inc (ARCT) market capitalization is $369.4M on the latest cached snapshot.
Arcturus Therapeutics Holdings Inc (ARCT) cached previous close $13.98; day range $14.06 – $15.12; volume 496,628. Session quote: https://lician.com/quote/arct
Arcturus Therapeutics Holdings Inc (ARCT) latest cached earnings event is "ARCT earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARCT filing is 8-K · Sep 23, 2026. Filings: https://lician.com/sec/arct